Year: 2004
Type: editorial
Abstract: Prostate cancer has become a major public health issue. The application of screening technology incorporating digital rectal examination, measurement of PSA and use of transrectal ultrasonography has identified a huge reservoir of previously undetected cases. For a short time, this gave the semblance of an ‘epidemic’, although it soon became clear that this was not the case and only reflected the reservoir effect. Despite the absence of definitive, structured proof of the benefit of screening for prostate cancer, politicians, health authorities, advocacy groups and innocent bystanders have weighed into the debate on the benefits of screening and early intervention ( Raghavan, 1997 ). This has focused attention on all aspects of prostate cancer care, including the utility of cytotoxic chemotherapy ( Beer and Raghavan, 2000 ).
Source: British Journal of Cancer
Author: D Raghavan
Institution: Cleveland Clinic
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,190
OpenAlex ID: W2072866100
